17.77
-0.48(-2.63%)
Currency In USD
| Previous Close | 18.25 |
| Open | 18.01 |
| Day High | 18.39 |
| Day Low | 17.67 |
| 52-Week High | 21.73 |
| 52-Week Low | 5.28 |
| Volume | 1.61M |
| Average Volume | 6.34M |
| Market Cap | 2.91B |
| PE | -27.34 |
| EPS | -0.65 |
| Moving Average 50 Days | 10.32 |
| Moving Average 200 Days | 8.25 |
| Change | -0.48 |
If you invested $1000 in Wave Life Sciences Ltd. (WVE) 10 years ago, it would be worth $1,139.83 as of December 28, 2025 at a share price of $17.77. Whereas If you bought $1000 worth of Wave Life Sciences Ltd. (WVE) shares 5 years ago, it would be worth $2,068.68 as of December 28, 2025 at a share price of $17.77.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
GlobeNewswire Inc.
Dec 10, 2025 2:50 AM GMT
CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”),
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
GlobeNewswire Inc.
Dec 08, 2025 9:01 PM GMT
CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”),
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
GlobeNewswire Inc.
Dec 08, 2025 12:30 PM GMT
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% reduction in total body fat (3.5 lbs; p=0.07), and a 3.2%